Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States

Anne-Laure Guillermin; Adam Lloyd; Jennie H. Best; Mary Beth DeYoung; Yevgeniy Samyshkin; Julia Aledort Gaebler

doi:10.3111/13696998.2012.670677

Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States

Journal of Medical Economics ◽

10.3111/13696998.2012.670677 ◽

2012 ◽

Vol 15 (4) ◽

pp. 654-663 ◽

Cited By ~ 12

Author(s):

Anne-Laure Guillermin ◽

Adam Lloyd ◽

Jennie H. Best ◽

Mary Beth DeYoung ◽

Yevgeniy Samyshkin ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

The United States ◽

Consequence Analysis ◽

Cost Consequence ◽

Diabetes Patients

Download Full-text

PDB36 LONG-TERM COST-CONSEQUENCE ANALYSIS OF EXENATIDE ONCE WEEKLY VERSUS SITAGLIPTIN OR PIOGLITAZONE IN TYPE 2 DIABETES PATIENTS IN THE UNITED STATES

Value in Health ◽

10.1016/s1098-3015(11)72094-0 ◽

2010 ◽

Vol 13 (7) ◽

pp. A290 ◽

Cited By ~ 1

Author(s):

Gaebler J Aledort ◽

Y Samyshkin ◽

ALG Guillermin ◽

A Lloyd

Keyword(s):

United States ◽

Type 2 Diabetes ◽

The United States ◽

Consequence Analysis ◽

Cost Consequence ◽

Diabetes Patients

Download Full-text

The Effect of Early Response to GLP-1 RA Therapy on Long-Term Adherence and Persistence Among Type 2 Diabetes Patients in the United States

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2019.18429 ◽

2019 ◽

Vol 25 (6) ◽

pp. 669-680

Author(s):

Emily Durden ◽

Michael Liang ◽

Robert Fowler ◽

Ulrik Haagen Panton ◽

Emina Mocevic

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Early Response ◽

The United States ◽

Diabetes Patients

Download Full-text

Budget impact of treating commercially insured type 1 and type 2 diabetes patients in the United States with insulin degludec compared to insulin glargine

Current Medical Research and Opinion ◽

10.1080/03007995.2016.1251893 ◽

2016 ◽

Vol 33 (2) ◽

pp. 231-238 ◽

Cited By ~ 2

Author(s):

James Weatherall ◽

Lisa Bloudek ◽

Sarah Buchs

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Insulin Glargine ◽

Budget Impact ◽

The United States ◽

Insulin Degludec ◽

Diabetes Patients

Download Full-text

S86 Real World Evidence Evaluation of the Characteristics of Chronic Pancreatitis and Type 2 Diabetes Patients Treated With Pancrelipase in the United States

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000772324.35229.50 ◽

2021 ◽

Vol 116 (1) ◽

pp. S37-S37

Author(s):

Jonathan Rosenberg ◽

Chris LaVallee ◽

Manchikanti Nagarjuna Reddy ◽

Prafullakumar Seelam ◽

Olivia Li ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Chronic Pancreatitis ◽

Real World ◽

The United States ◽

Real World Evidence ◽

Evidence Evaluation ◽

Diabetes Patients

Download Full-text

Usage and Perceptions of Pen Injectors for Diabetes Management: A Survey of Type 2 Diabetes Patients in the United States

Journal of Diabetes Science and Technology ◽

10.1177/193229681200600325 ◽

2012 ◽

Vol 6 (3) ◽

pp. 686-694 ◽

Cited By ~ 7

Author(s):

Deborah Toscano ◽

Jennifer Brice ◽

Christina Alfaro

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Diabetes Management ◽

The United States ◽

Diabetes Patients

Download Full-text

Abstract #289: Assessing Unmet Needs for Type 2 Diabetes Patients Treated with Basal Insulin in the United States

Endocrine Practice ◽

10.1016/s1530-891x(20)44997-3 ◽

2016 ◽

Vol 22 ◽

pp. 78-79

Author(s):

Jakob Langer ◽

Ye Tian ◽

Wayne Weng ◽

Cory Gamble ◽

Michelle Mocarski

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Basal Insulin ◽

Unmet Needs ◽

The United States ◽

Diabetes Patients

Download Full-text

Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis

Journal of Medical Economics ◽

10.3111/13696998.2012.688903 ◽

2012 ◽

Vol 15 (6) ◽

pp. 1039-1050 ◽

Cited By ~ 16

Author(s):

Elise M. Pelletier ◽

Manjiri Pawaskar ◽

Paula J. Smith ◽

Jennie H. Best ◽

Richard H. Chapman

Keyword(s):

United States ◽

Type 2 Diabetes ◽

The United States ◽

Economic Outcomes ◽

Database Analysis ◽

Claims Database ◽

Diabetes Patients

Download Full-text

PDG66 METFORMIN DOSAGE PATTERNS IN TYPE 2 DIABETES PATIENTS IN A REAL-WORLD HEALTHCARE SETTING IN THE UNITED STATES

Value in Health ◽

10.1016/j.jval.2019.04.745 ◽

2019 ◽

Vol 22 ◽

pp. S173-S174

Author(s):

R. Mahabaleshwarkar ◽

A. DeSantis

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Real World ◽

Healthcare Setting ◽

The United States ◽

Diabetes Patients

Download Full-text

Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2020.108531 ◽

2020 ◽

pp. 108531

Author(s):

Rohan Mahabaleshwarkar ◽

Andrea DeSantis

Keyword(s):

United States ◽

Type 2 Diabetes ◽

Real World ◽

The United States ◽

Real World Setting ◽

Diabetes Patients

Download Full-text

Modeling the Long Term Economic Benefits of a Patient-Adjusted Mealtime Insulin Titration Algorithm among Patients with Type 2 diabetes in the united States

Value in Health ◽

10.1016/j.jval.2015.03.342 ◽

2015 ◽

Vol 18 (3) ◽

pp. A58-A59

Author(s):

N.O. Numapau ◽

D.R. Murphy ◽

B.H. Curtis ◽

J.C. Gahn ◽

S. Curtis ◽

...

Keyword(s):

United States ◽

Type 2 Diabetes ◽

The United States ◽

Economic Benefits ◽

Mealtime Insulin ◽

Titration Algorithm

Download Full-text